Developing a Resilient Strategy, Not a Reactive One With additional oral GLP-1 options coming on the market, patients and physicians have more choices than ever
The update comes soon after the World Health Organization updated its guidelines for obesity treatment, citing the combination of GLP-1 drugs, a healthy diet and exercise being integral for success among patients
Klein KR, Clemmensen KKB, Fong E, Olsen S, Abrahamsen T, Lingvay I
The subcutaneous formulation marketed as Ozempic is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
"Novo Nordisk launching the Wegovy pill on Ro from Day 1, and leveraging Ro's vertically integrated infrastructure, is an extremely innovative approach to increase access to the next generation of blockbuster drugs," said Zach Reitano, Ro co-founder and CEO